Pulse Biosciences
PLSE
43 hedge funds and large institutions have $15.6M invested in Pulse Biosciences in 2023 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 5 closing their positions.
23,850% more call options, than puts
Call options by funds: $1.44M | Put options by funds: $6K
42% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 12
2.62% less ownership
Funds ownership: 9.66% → 7.04% (-2.6%)
4% less funds holding
Funds holding: 45 → 43 (-2)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
40% less capital invested
Capital invested by funds: $26.1M → $15.6M (-$10.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GAM
Griffin Asset Management
New York
|
+$500K |
| 2 |
Renaissance Technologies
New York
|
+$444K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$319K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$283K |
| 5 |
BlackRock
New York
|
+$278K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$258K |
| 2 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$107K |
| 3 |
Goldman Sachs
New York
|
-$73.9K |
| 4 |
WIM
Westside Investment Management
Santa Monica,
California
|
-$70.7K |
| 5 |
New York State Common Retirement Fund
Albany,
New York
|
-$42.4K |
PLSE Hedge Fund Activity: Q3 2023 in Review
43 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q3 2023, worth a combined $15.6M — down 40% from $26.1M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of PLSE and 4 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 17 added.
The largest buyer was Griffin Asset Management, adding an estimated $500K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $258K sold.
- 43 institutional investors held Pulse Biosciences (PLSE) as of Q3 2023, down from 45 in Q2 2023.
- Funds reported $15.6M of Pulse Biosciences stock for Q3 2023, down 40% quarter-over-quarter.
- 4 funds opened new Pulse Biosciences positions in Q3 2023 and 5 closed out, a net change of -1 holder.
- The largest Pulse Biosciences buyer in Q3 2023 was Griffin Asset Management, an estimated $500K added.
- The largest Pulse Biosciences seller in Q3 2023 was Susquehanna International Group, an estimated $258K sold.
Based on aggregated 13F filings for Q3 2023.